AIM/GENI (AIM/GENI)

London Stock Exchange AIM: AIM/GENI · GBX

GBX 0.70

+0.00 (+0.4%)· Recorded snapshot

Market cap	5.3M
Revenue (ttm)	2.6M
Net income (ttm)	-5.3M
EPS (ttm)	-GBX 0.01
Shares out	753M
Volume	473,776
Beta	0.66

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.6M
Net income (ttm): -5.3M
EPS (ttm): -GBX 0.01
Market cap: 5.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-222.7

P25 n/aP50 n/aP75 n/a

ROIC-136.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AIM/GENI indicators

Market & fundamental data

Available fields

187

Groups with data

Currency

GBP

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United Kingdom
Country code	UK
Earnings date	2026-09-29
Employees	44
Employees change	2
Employees growth	4.76%
Enterprise value	GBX 3.4M
Exchange	London Stock Exchange AIM
Financial currency	GBP
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2018
Industry	Medical - Diagnostics & Research
Is primary listing	Yes
ISIN number	GB00BL97B504
Last earnings date	2026-09-29
Last refreshed	2026-10-28
Market cap	GBX 5.3M
Next earnings date	2027-05-21
Price	GBX 0.70
Price currency	GBX
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-28
Symbol	aim/GENI
Website	https://www.genincode.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-155.36%
EV/Sales	1.3x
FCF / EV yield	-118.39%
FCF yield	-76.03%
P/B ratio	2.56x
P/S ratio	2.03x
Price / tangible book value	2.67x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-210.12%
EBITDA margin	-206.93%
Gross margin	57.29%
Operating margin	-210.12%
Pretax margin	-208.35%
Profit margin	-202.42%
Profit per employee	GBX -119,568
Revenue per employee	GBX 59,068
ROA	-88.1%
ROA (5Y)	-69.84%
ROCE	-264.58%
ROE	-222.69%
ROE (5Y)	-307.29%
ROIC	-136.14%
SBC / revenue	27.32%
Tax / revenue	-5.93%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	5
EPS growth years	2
Gross profit growth	-3.62%
Gross profit growth (Q)	-37.1%
Gross profit growth 3Y	22.2%
Gross profit growth 5Y	18.36%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-10.81%
Revenue growth (Q)	-29.78%
Revenue growth (QoQ)	-23.68%
Revenue growth 3Y	14.84%
Revenue growth 5Y	17.77%
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	GBX -48,000
Depreciation and amortization	GBX 83,000
EBIT	GBX -5.5M
EBITDA	GBX -5.4M
EPS	GBX -0.01
FCF per share	GBX -0.01
Financing cash flow	GBX 4.2M
Free cash flow	GBX -4M
Free cash flow minus SBC	GBX -4.7M
Gross profit	GBX 1.5M
Income taxes	GBX -154,000
Investing cash flow	GBX -7,000
Net borrowing	GBX -88,000
Net cash flow	GBX -454,000
Net income	GBX -5.3M
Operating cash flow minus SBC	GBX -4.7M
Operating income	GBX -5.5M
Revenue	GBX 2.6M
Stock-based compensation	GBX 710,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-11.96
Book value per share	GBX 0.00
Debt / equity	0.05
Long-term assets	GBX 276,000
Long-term liabilities	GBX 2,000
Net cash (debt)	GBX 1.9M
Net cash / market cap	35.78%
Net cash growth	-16.07%
Net debt / equity	-0.91
Piotroski F-Score	3
Property, plant and equipment	GBX 188,000
Shareholders' equity	GBX 2.1M
Tangible book value	GBX 2M
Tangible book value per share	GBX 0.00
Total assets	GBX 3.5M
Total cash	GBX 2M
Total debt	GBX 98,000
Total liabilities	GBX 1.5M
WACC	7.71%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.67
Current assets	GBX 3.3M
Current liabilities	GBX 1.5M
Current ratio	2.22
Inventory turnover	12.27
Net working capital	GBX -98,000
Quick ratio	2.12
Working capital	GBX 1.8M
Working capital turnover	1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-126.64%
Shareholder yield	-126.64%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	GBX 0.93
1D price change	0.43%
1M price change	-19.66%
1M total return	-19.66%
1W price change	4.15%
1W total return	4.15%
1Y price change	-78.37%
1Y return CAGR	-78.39%
1Y total return	-78.37%
20-day SMA	GBX 0.66
200-day SMA	GBX 1.00
3M price change	-15.3%
3M total return	-14.79%
3Y price change	-91.35%
3Y return CAGR	-55.76%
3Y total return	-91.35%
50-day SMA	GBX 0.80
50-day SMA vs 200-day SMA	50under200
52-week high	GBX 4.90
52-week high date	2025-12-04
52-week low	GBX 0.56
52-week low date	2026-10-19
5Y price change	-98.15%
5Y return CAGR	-54.98%
5Y total return	-98.15%
6M price change	-37.79%
6M total return	-37.51%
All-time high	GBX 48.00
All-time high date	2021-07-22
All-time low	GBX 0.56
All-time low date	2026-10-19
Average true range (ATR)	GBX 0.10
Average volume	1.8M
Beta (1Y)	0.25
Beta (2Y)	0.09
Beta (5Y)	0.66
Change from 52-week high	-85.65%
Change from 52-week low	25.31%
Change from all-time high	-98.54%
Change from all-time low	25.31%
Change from open	7.82%
Day's gap	-6.86%
Dollar volume	GBX 333,065
High price	GBX 0.75
Low price	GBX 0.65
Monthly RSI	33.7
Open price	GBX 0.65
Position in 52-week range	52.04%
Previous close	GBX 0.70
Price vs 150-day SMA	-24.53%
Price vs 20-day SMA	6.73%
Price vs 200-day SMA	-29.58%
Price vs 50-day SMA	-12.17%
Relative volume	0.26
RSI	48.39
Sharpe ratio	-1.02
Sharpe ratio (3Y)	-0.11
Sharpe ratio (5Y)	-0.22
Sortino ratio	-1.41
Sortino ratio (3Y)	-0.18
Sortino ratio (5Y)	-0.43
Volume	473.8K
Weekly RSI	38.1
YTD price change	-70.71%
YTD total return	-70.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	365.9M
Shares change (QoQ)	122.29%
Shares change (YoY)	126.64%
Shares held by insiders	16.11%
Shares held by institutions	40.01%
Shares outstanding	753M

Deeper analysis on AIM/GENI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AIM/GENI report

Is a complete AIM/GENI research report available?

No complete published report is available for aim/GENI (AIM/GENI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/GENI (AIM/GENI)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/GENI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/GENI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIM/GENI

Frequently asked questions